As more healthy individuals seek AOM prescriptions for cosmetic or preventive reasons, insurers must consider how to interpret such use in underwriting and build an understanding of the nuanced, evolving interplay among pharmacologic intervention, lifestyle behaviors, and long-term outcomes
Reimagining Rural India: CEAHs Vision for Animal Husbandry in Viksit Bharat In an exclusive interaction, Dr Mahesh PS, Joint Commissioner and Director of CEAH, shares insights on the future of India's livestock sector
IBS is a common functional gut disorder, affecting an estimated 1015% of adults (especially women), and is characterized by chronic abdominal pain and changes in bowel habits
In non-randomized interventions, FIM therapies are associated with BMI reductions of 0.40.6 kg/m 2 [224]
Am J Physiol Physiol 297(6):F1647F1655 Meier JJ (2012) GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus